Adriblastine and sudden death Patient Reports February 10, 2012
Adriblastine Side Effects Report #5042978-1
Adriblastine side effect was reported by a Physician from FRANCE on June 13, 2006. Male patient, 37 years of age, was diagnosed with multiple myeloma
and was treated with Adriblastine. After drug was administered, patient experienced the following side effects: agranulocytosis. Adriblastine dosage: 50 MG/25 ML, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE PHOSPHATE, CIPROFLOXACIN, CEFTAZIDIME PENTAHYDRATE, AUGMENTIN, ARANESP. Patient died on 04/21/2006.Adriblastine Side Effects Report #5397216-7
Adriblastine side effect was reported by a Health Professional from FRANCE on July 13, 2007. Female patient was diagnosed with liposarcoma, prophylaxis, vomiting and was treated with Adriblastine. Adriblastine dosage: unknown. During the same period patient was treated with HOLOXAN, NEULASTA, EMEND, ZOFRAN, PRIMPERAN, XANAX. Patient died on 02/16/2007.
Adriblastine and sudden death 